Abstract
The crystalline arthropathies are a group of disorders in which crystals form in joints or surrounding soft tissue causing inflammation. The most common crystalline diseases in clinical practice are gout and pseudogout (CPPD disease). Gout is characterized by deposition of monosodium urate crystals in the joint and often high serum uric acid levels. Pseudogout is characterized by calcium pyrophosphate dihydrate crystals and sometimes can be secondary to a metabolic condition. The acute management of these conditions relies on reducing inflammation although the long-term treatment strategies differ. If not treated early, these conditions can cause permanent joint damage and disability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chen-Xu M, Yokose C, Pillinger M, Choi HK. Contemporary prevalence of Gout and Hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015-2016) and decadal trends (NHANES 2007-2016) [abstract]. Arthritis Rheumatol. 2018;70(suppl 9):1256–7.
Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK general practice research database, 1990–1999. Ann Rheum Dis. 2005;64:267–72.
Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent Gout: a systematic review. J Rheumatol. 2017;44(3):388–96.
Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186–91.
Cleophas MC, Joosten LA, Stamp LK, et al. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med. 2017;10:129–42.
Lachmann HJ, Quartier P, So A, Hawkins PN. The emerging role of interleukin-1β in autoinflammatory diseases. Arthritis Rheum. 2011;63:314–24. https://doi.org/10.1002/art.30105.
Hainer BL, Matheson E, Wilkes RT. Diagnosis, treatment, and prevention of Gout. Am Fam Physician. 2014;90(12):831–6.
Raddatz DA, Mahowald ML, Bilka PJ. Acute polyarticular gout. Ann Rheum Dis. 1983;42(2):117.
Neogi T, Jansen TLTA, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74:1789–98.
Ogdie A, Taylor WJ, Neogi T, et al. Performance of ultrasound in the diagnosis of gout in a multicenter study: comparison with monosodium urate monohydrate crystal analysis as the gold standard. Arthritis Rheumatol. 2017;69:429–38.
Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, Neogi T. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71(9):1448.
Nielsen SM, et al. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis. 2017;76(11):1870. Epub 2017 Sep 2
Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003;17(5–6):397.
Vargas-Santos, et al. Management of gout and hyperuricemia in CKD. Am J Kidney Dis. 2017;70(3):422–39.
Chattopadhyay I, Shetty HGM, Routledge PA, Jeffery J. Colchicine induced rhabdomyolysis. Postgrad Med J. 2001;77(905):191.
Abhishek A. Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy. Rheum Dis Clin N Am. 2014;40(2):177–91.
Pang L, et al. Pseudogout-associated inflammatory calcium pyrophosphate Dihydrate microcrystals induce formation of neutrophil extracellular traps. J Immunol. 2013;190(12):6488–500.
Nalbant S, et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthr Cartil. 2003;11(1):50–4.
Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575–84. http://dx.doi.org.libproxy.lib.unc.edu/10.1056/NEJMra1511117
Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C. Calcium pyrophosphate crystal deposition disease: diagnosis and treatment. Open Access Rheumatol. 2014;6:39–47. Published 2014 May 8. https://doi.org/10.2147/OARRR.S39039.
Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70:571–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
ElTaraboulsi, R. (2021). Crystalline Arthropathy. In: Esther, R.J. (eds) Clinical Foundations of Musculoskeletal Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-42894-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-42894-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42893-8
Online ISBN: 978-3-030-42894-5
eBook Packages: MedicineMedicine (R0)